| Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS2 | | homo-2-mer | 12-394 | 2×TLA; 2×PV2; |
| Assess |
| Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS10 | | homo-2-mer | 12-394 | 2×PV0; 2×TLA; |
| Assess |
| Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PA7 | | homo-2-mer | 12-394 | 2×PFT; 2×TLA; |
| Assess |
| Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS8 | | homo-2-mer | 12-394 | 2×PV8; 2×TLA; |
| Assess |
| Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS35 | | homo-2-mer | 12-392 | 2×TLA; 2×P35; |
| Assess |
| Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PA1 | | homo-2-mer | 12-392 | 2×PV1; 2×TLA; |
| Assess |
| crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic … | | homo-2-mer | 14-393 | |
| Assess |
| crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic … | | homo-2-mer | 14-393 | 2×TF1; |
| Assess |
| crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic … | | homo-2-mer | 14-393 | 2×TF3; |
| Assess |
| crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic … | | homo-2-mer | 14-393 | 2×TF2; |
| Assess |
| crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic … | | homo-2-mer | 14-393 | 2×ATP; 2×TF1; 2×MG; |
| Assess |
| Crystal structure of human PDK2 complexed with GM10030 | | homo-2-mer | 6-385 | 2×SO4; 1×GOL; 2×EH0; |
| Assess |
| Crystal structure of human PDK2 complexed with GM67520 | | homo-2-mer | 6-384 | 3×GOL; 4×SO4; 2×EH3; |
| Assess |
| crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic … | | homo-2-mer | 14-384 | 2×ADP; 2×MG; 2×TF4; |
| Assess |
| Crystal structure of pyruvate dehydrogenase kinase isoform 2 in complex with inhibitor PS46 | | homo-2-mer | 11-373 | 2×P46; |
| Assess |
| VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupt… | | homo-2-mer | 14-374 | 2×TF3; 4×MG; 2×7TJ; |
| Assess |
| VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupt… | | homo-2-mer | 15-374 | 2×TF3; 2×MG; 2×SZ6; |
| Assess |
| Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 5 | | homo-2-mer | 16-374 | 2×CL; 6×ACT; 4×DMS; 2×6I4; |
| Assess |
| Crystal structure of human PDK2 complexed with an allosteric inhibitor compound 8c | | homo-2-mer | 15-373 | 2×FLC; 3×PEG; 1×GOL; 1×SO4; 2×EGX; |
| Assess |
| Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 13 | | homo-2-mer | 16-374 | 2×CL; 4×ACT; 4×DMS; 2×J0F; |
| Assess |
| Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 2 | | homo-2-mer | 16-374 | 2×CL; 4×ACT; 4×DMS; 2×42A; |
| Assess |
| Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 7 | | homo-2-mer | 16-374 | 5×ACT; 4×DMS; 2×67V; 1×CL; |
| Assess |
| Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 1 | | homo-2-mer | 16-374 | 2×CL; 4×ACT; 4×DMS; 2×W6P; |
| Assess |
| Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 20 | | homo-2-mer | 16-372 | 2×CL; 2×ACT; 4×DMS; 2×5ZP; |
| Assess |
| Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures | | monomer | 14-378 | 1×TF3; 1×NL8; 1×DMS; 1×CL; |
| Assess |
| Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures | | monomer | 14-378 | 1×MG; 1×NN8; 1×TF3; |
| Assess |
| Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures | | monomer | 14-377 | 1×TF3; 1×NMW; 1×DMS; |
| Assess |
| Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures | | monomer | 14-375 | 1×TF3; 1×NLZ; 1×DMS; 1×CL; |
| Assess |
| Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixtures | | monomer | 14-375 | 1×TF3; 1×MG; 1×NN8; |
| Assess |
| Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate… | | monomer | 15-374 | 1×7FE; 1×TF3; 2×CL; |
| Assess |
| Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate… | | monomer | 15-374 | 1×7FW; 1×TF3; 3×CL; |
| Assess |
| Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate… | | monomer | 15-374 | 1×TF3; 1×7F9; 1×MG; |
| Assess |
| Application of Off-Rate Screening in the Identification of Novel Pan-Isoform Inhibitors of Pyruvate… | | monomer | 15-374 | 1×7FV; 1×TF3; 4×CL; |
| Assess |